Skip to main content

Market Overview

Anthem-Cigna Deal Will Still Happen, Leerink Says

Share:

CIGNA Corporation (NYSE: CI) is likely to accept a bid of $190 a share from Anthem Inc (NYSE: ANTM) an analyst said Tuesday.

Cigna, which rejected a $184 a share cash-and-stock bid from Anthem on Sunday, traded recently at $164.75, up $1.35.

Leerink's Ana Gupta said the deal between the two insurance giants "will come to fruition" although Anthem may boost its latest bid by about 3 percent.

Gupta also said Humana Inc (NYSE: HUM) is unlikely to serve as a "second choice" for Anthem.

Aetna Inc (NYSE: AET) made a recent offer for Humana, according to a report last week by The Wall Street Journal which the companies haven't confirmed.

Aetna "looks like the only viable dance partner" for Humana, according to Gupte, who said Humana will fetch at least $210 a share.

Humana traded recently at $189.86, down $0.04.

Cigna, in rejecting Anthem's bid Sunday, raised anti-trust and governance concerns, which Gupte said are "addressable."

Cigna's Chief Executive David Cordani apparently doesn't want to get left out after a deal, and Gupte said a "co-chairman" role will probably be offered.

If Anthem sweetens its offer for Cinga, it would be the fifth in a string of offers for Cigna that Anthem has made, starting with a bid of $174 a share on June 3, according to a letter disclosed Sunday.

Latest Ratings for CI

DateFirmActionFromTo
Mar 2022MizuhoMaintainsBuy
Feb 2022SVB LeerinkMaintainsMarket Perform
Feb 2022Morgan StanleyMaintainsEqual-Weight

View More Analyst Ratings for CI

View the Latest Analyst Ratings

 

Related Articles (CI + ANTM)

View Comments and Join the Discussion!

Posted-In: Ana Gupte LeerinkAnalyst Color Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com